Patient-reported QoL in anal cancer survivors 3 and 6 years after treatment-results from the Swedish national ANCA study.

Anna AxelssonMia JohanssonDavid BockEva HaglindHanna de la CroixPer J NilssonEva Angenete

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2022)

Patients treated for anal cancer reported bother regarding several bodily functions as well as poor QoL both at 3 and 6 years without much improvement. Bother was also associated with low QoL indicating that function-related bother should be addressed.

Keyphrases

patient reported
high grade
papillary thyroid
young adults
childhood cancer
quality improvement
squamous cell carcinoma
drug induced